Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Onto Innovation Inc ONTO

Technology Semiconductor Equipment & Materials
Onto Innovation Inc. is engaged in the design, development, manufacture and support of metrology and inspection tools for the semiconductor industry. The Company’s products include Automated Metrology Systems; Integrated Metrology Systems; Silicon Wafer All-surface Inspection/Characterization; Macro Defect Inspection; Automated Defect Classification and Pattern Analysis; Yield Analysis; Opaque... see more

Recent & Breaking News (NYSE:ONTO)

Nanometrics Reports Third Quarter 2016 Financial Results

GlobeNewswire October 27, 2016

Nordic Nanovector and Heidelberg Pharma enter collaboration to develop novel antibody-drug conjugates (ADCs) targeting leukaemias

Business Wire October 26, 2016

Nanobiotix’s Partner, PharmaEngine, Has Launched a New NBTXR3 Clinical Trial in Head and Neck Cancers in Asia

Business Wire October 21, 2016

PharmaEngine, partenaire de Nanobiotix, a lancé en Asie un nouvel essai clinique avec le NBTXR3, chez les patients atteints de cancers de la tête et du cou

Business Wire October 21, 2016

Nanobiotix's partner, PharmaEngine, has launched a new NBTXR3 clinical trial in head and neck cancers in Asia

GlobeNewswire October 20, 2016

Nordic Nanovector ASA: Issuance of Restricted Stock Units (RSUs) to the New Board Member Joanna Horobin

Business Wire October 20, 2016

Nordic Nanovector Announces the Appointment of Joanna Horobin, MD, as Non-Executive Board Director

Business Wire October 12, 2016

Nordic Nanovector ASA: Extraordinary General Meeting Held

Business Wire October 12, 2016

Nanobiotix : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Business Wire October 11, 2016

Nanometrics to Announce Third Quarter Financial Results on October 27, 2016

GlobeNewswire October 10, 2016

Nordic Nanovector and LegoChem Biosciences Enter Collaboration to Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias

Business Wire October 10, 2016

Nanobiotix renforce son équipe dirigeante aux Etats-Unis avec le recrutement d’un Directeur du Développement Clinique et une Directrice des Relations Investisseurs

Business Wire October 3, 2016

Nanobiotix Strengthens U.S. Leadership with Appointments of Head of U.S. Clinical Development and Director of Investor Relations

Business Wire October 3, 2016

Nordic Nanovector: Safety Review Committee supports dose escalation with Betalutin® in Lymrit 37-01 trial pending safety data from cohort receiving higher pre-dosing

Business Wire September 23, 2016

Nordic Nanovector ASA – Changes to the Board of Directors and Notice of Extraordinary General Meeting

Business Wire September 21, 2016

Bpifrance accorde un prêt de 2M€ à taux zéro à Nanobiotix pour accompagner la dernière phase de développement du produit NBTXR3

Business Wire September 19, 2016

Bpifrance Grants Nanobiotix a 2M€ Interest-Free Loan to Support Final Development Stage of Lead Product, NBTXR3

Business Wire September 19, 2016

Bpifrance grants Nanobiotix a 2MEU interest-free loan to support final development stage of lead product, NBTXR3

GlobeNewswire September 19, 2016

Nanobiotix dépose sa première demande d’autorisation de mise sur le marché (marquage CE) pour son produit NBTXR3

Business Wire September 13, 2016

Nanobiotix announces submission for first market approval of lead product NBTXR3 in Europe

Business Wire September 13, 2016